Harry L. Leider, MD, MBA, FACPE

Harry L. Leider, MD, MBA, FACPE, is Chief Medical Officer of Nsight Health. A senior healthcare executive and board member with more than 25 years of experience, Dr. Leider focuses on combining digital health, AI, and the skills of clinical teams to improve care for people living with chronic illness, with deep experience in remote patient monitoring, telemedicine, population health, and laboratory medicine. He previously served as Chief Executive Officer of ZEO ScientifiX, as Executive Vice President and Chief Medical Officer of Gelesis, and as Chief Medical Officer and Group Vice President at Walgreens Boots Alliance, where he led the creation of the company's first telemedicine and remote health monitoring programs. He is a past President and Board Chairman of the American Association of Physician Leadership and has held faculty appointments at Harvard Medical School, the Johns Hopkins Carey School of Business, and the University of Pennsylvania School of Medicine.

Nsight-Optum economic analysis: estimated first-year total medical savings of $2,467 in hypertension, $3,012 in diabetes, and $2,483 in chronic kidney disease per member per year

Remote Patient Monitoring Cost Savings in High-Risk Medicare Patients: Early Evidence From the Nsight-Optum Economic Analysis

Remote Patient Monitoring (RPM)Chronic Care Management (CCM)Value-Based Care Clinical Evidence

Access Nsight

Remote patient monitoring clinical outcomes from Nsight Health: 11.5 mmHg average systolic BP reduction, 29.6 mmHg in Stage 2 hypertension, 55 mg/dL glucose reduction

Remote Patient Monitoring Clinical Outcomes: What the Evidence Shows Across Five Chronic Conditions

Harry L. Leider, MD, MBA, FACPE

Remote Patient Monitoring (RPM)Chronic Care Management (CCM)Clinical Evidence

Access Nsight